We have been working on an anticancer drug delivery system based on PLGA-b-PEG copolymer nanoparticles, and now are looking for colleagues who are expert in cancer animal models and related in vivo experiments. Our preferential tumor model is MCF7 breast cancer. Please contact me for further detailed information. Thank you.
Dear Dr. Samadi,
It is of my great pleasure to meet you here and read your declare of interest. First of all, I should admit my intense enthusiasm to build up international collaborative relations, especially with dear Iranians abroad. However, considering the restrictions and difficulties of relationship between Iran and the US, I actually don't know by what means a collaboration in such dimensions would be possible. I assume that it would be more feasible if first of all, a preliminary in vivo evaluation of this nanodrug delivery system is successfully completed in Iran, and thereafter we can collaborate with each other on preclinical and even translational bench to beside developments of the work.
Anyway, it is absolutely welcome if you come up with any other helpful suggestions about the possible ways that we could collaborate with each other. Thank you very much.
Best wishes & regards
Dear Hamed,
I appreciate your interest on this project. Actually, at this stage our plan is to start the tumor efficacy studies of our delivery system on mouse breast cancer tumor models MCF7, MDA-MB-435 or MDA-MB-231. However, for Biodistribution and pharmacokinetic studies we would need to have breast cancer models of SD rats. I think we could build up a good collaboration at these stages of animal studies, if you are seriously interested and ready for a firm commitment.
- Badges
- Science topic
- Similar topics
- Human-Computer Interaction
- Collaboration